Palace backs Sinovac COVID-19 jabs for elderly

  • 📰 ABSCBNNews
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 83%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

Malacañang said on Thursday it was 'very supportive' of the option to give the country's 9 million senior citizens COVID-19 shots from Beijing-based Sinovac Biotech.

MANILA — Malacañang said on Thursday it was "very supportive" of the option to give the country's 9 million senior citizens COVID-19 shots from Beijing-based Sinovac Biotech.

"Very supportive po [d'yan ang Malacañang] dahil alam natin na napakadaming bansa na sa daigdig ang gumagamit ng Sinovac para sa senior citizens," said Palace spokesman Harry Roque. "I think steps will be taken to ask the local representative of Sinovac to present additional data sa FDA para mabago po iyong EUA na inisyu ng FDA. Ang kailangan lang naman po ng FDA ay additional data," said Roque.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Sinovac has no published data of Phase 3 clinical trials. Moreso, they do not have any published data for trials conducted on the elderly. How crazy is this government to risk our mothers and fathers just to please the chinese communist party.

Unahin si duque

Lahat na nasa Gabinete at gobyerno ni Digong na ang edad ay 60 years old and above ang dapat makita ng publiko unahin turukan ng Sinovac. Ipakita sa Sambayanang Pilipino ay inyong katapatan at lakas ng loob sa pag serbisyo sa bansa

yan ang problema pag ang mga pulitiko mas marunong pa sa mga doktor...

Duterte, Duque, Lorenzana muna ang mauna.

soo, dapat magpabakuna na sina Duque? 😏

OUSTDUTERTENOW DutertePalpak

No to ChinaVac!

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.